Schroder Investment Management Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-317,500
Closed -$985K 1655
2021
Q4
$985K Sell
317,500
-6,685
-2% -$22.5K ﹤0.01% 1035
2021
Q3
$1.17M Hold
324,185
﹤0.01% 1079
2021
Q2
$1.16M Sell
324,185
-32,702
-9% -$115K ﹤0.01% 1106
2021
Q1
$1.4M Sell
356,887
-14,644
-4% -$60.5K ﹤0.01% 1080
2020
Q4
$1.56M Buy
371,531
+327,286
+740% +$1.26M ﹤0.01% 1048
2020
Q3
$169K Buy
+44,245
New +$188K ﹤0.01% 1200

Other funds holding BDSI

Schroder Investment Management Group's BDSI Position: Q1 2022 in Review

Schroder Investment Management Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 317,500 shares — an estimated $985K sold.

Schroder Investment Management Group first reported a position in BDSI in Q3 2020 and held it in 6 quarters. The position peaked at $1.56M in Q4 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Schroder Investment Management Group reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 317,500 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $985K.
  • Schroder Investment Management Group first reported a position in BioDelivery Sciences International, Inc. in Q3 2020 and held it in 6 quarters.
  • Schroder Investment Management Group's BioDelivery Sciences International, Inc. position peaked at $1.56M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.